JPH01191694A - Substance having antitumor activity - Google Patents
Substance having antitumor activityInfo
- Publication number
- JPH01191694A JPH01191694A JP63015754A JP1575488A JPH01191694A JP H01191694 A JPH01191694 A JP H01191694A JP 63015754 A JP63015754 A JP 63015754A JP 1575488 A JP1575488 A JP 1575488A JP H01191694 A JPH01191694 A JP H01191694A
- Authority
- JP
- Japan
- Prior art keywords
- alteromonas
- reaction
- substance
- sats2542
- active substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000126 substance Substances 0.000 title claims abstract description 24
- 230000000259 anti-tumor effect Effects 0.000 title claims abstract description 20
- 244000005700 microbiome Species 0.000 claims abstract description 29
- 241000590031 Alteromonas Species 0.000 claims abstract description 16
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims abstract description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims abstract description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000007864 aqueous solution Substances 0.000 claims abstract description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims abstract description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims abstract description 6
- 238000000354 decomposition reaction Methods 0.000 claims abstract description 6
- 238000000034 method Methods 0.000 claims abstract description 5
- 230000002378 acidificating effect Effects 0.000 claims abstract description 4
- 230000007935 neutral effect Effects 0.000 claims abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 4
- 150000001298 alcohols Chemical class 0.000 claims abstract description 3
- 238000002523 gelfiltration Methods 0.000 claims abstract description 3
- 239000003960 organic solvent Substances 0.000 claims abstract description 3
- 241000589563 Alteromonas sp. Species 0.000 claims abstract 2
- 239000013543 active substance Substances 0.000 claims description 18
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 238000010521 absorption reaction Methods 0.000 claims description 6
- 238000000862 absorption spectrum Methods 0.000 claims description 6
- 235000000346 sugar Nutrition 0.000 claims description 5
- 239000000243 solution Substances 0.000 claims description 4
- 230000003287 optical effect Effects 0.000 claims description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 238000001228 spectrum Methods 0.000 claims description 2
- 150000008163 sugars Chemical class 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 abstract description 12
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 abstract description 6
- 239000002246 antineoplastic agent Substances 0.000 abstract description 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 abstract description 2
- 235000018417 cysteine Nutrition 0.000 abstract description 2
- 239000010200 folin Substances 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- MYKOKMFESWKQRX-UHFFFAOYSA-N 10h-anthracen-9-one;sulfuric acid Chemical compound OS(O)(=O)=O.C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 MYKOKMFESWKQRX-UHFFFAOYSA-N 0.000 abstract 1
- OHJMTUPIZMNBFR-UHFFFAOYSA-N biuret Chemical compound NC(=O)NC(N)=O OHJMTUPIZMNBFR-UHFFFAOYSA-N 0.000 abstract 1
- 238000004040 coloring Methods 0.000 abstract 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 230000003442 weekly effect Effects 0.000 abstract 1
- 239000002609 medium Substances 0.000 description 23
- 229920001817 Agar Polymers 0.000 description 10
- 239000008272 agar Substances 0.000 description 10
- 230000001580 bacterial effect Effects 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000012010 growth Effects 0.000 description 6
- 235000013372 meat Nutrition 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 4
- 108010010803 Gelatin Proteins 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 3
- 229910002651 NO3 Inorganic materials 0.000 description 3
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 3
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 3
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- 239000012506 Sephacryl® Substances 0.000 description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 229960003104 ornithine Drugs 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- 239000013535 sea water Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- 208000028018 Lymphocytic leukaemia Diseases 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 208000003747 lymphoid leukemia Diseases 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000009897 systematic effect Effects 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 238000003794 Gram staining Methods 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 108091006629 SLC13A2 Proteins 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000012830 cancer therapeutic Substances 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000009229 glucose formation Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000015784 hyperosmotic salinity response Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000019086 sulfide ion homeostasis Effects 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本物質は、アルテロモナス(Alteromonas)
属に属する微生物の生産する新規な抗腫瘍活性物質SA
TS2542、該物質を生産する微生物、及び該物質の
製造方法に関する。[Detailed description of the invention] [Industrial application field] The present substance is derived from Alteromonas
A novel antitumor active substance SA produced by microorganisms belonging to the genus
TS2542, a microorganism that produces the substance, and a method for producing the substance.
癌治療の分野において化学療法剤の進歩はめざましいも
のがあるが、まだ不満足な点が多い。かような段階にあ
る現在、癌治療剤の開発をめざして、天然からの抗腫瘍
活性物質の単離は重要な課題となっている。Although there has been remarkable progress in chemotherapeutic agents in the field of cancer treatment, there are still many unsatisfactory points. At this stage, isolation of antitumor active substances from nature has become an important issue with the aim of developing cancer therapeutic agents.
微生物を含む天然源から見出された抗腫瘍活性物質は多
く知られているが、海洋性微生物から分離された抗腫瘍
活性物質はほとんど知られておらず、特にアルテロモナ
ス属微生物が生産する抗腫瘍活性物質は全く知られてい
ない。Although many antitumor active substances found from natural sources including microorganisms are known, very few antitumor active substances isolated from marine microorganisms are known, especially antitumor active substances produced by microorganisms of the genus Alteromonas. No active substances are known.
従って本発明は、抗腫瘍活性物質源として従来はとんど
研究されていなかった海洋性微生物から新しいタイプの
抗腫瘍活性物質を得ようとするものである。Therefore, the present invention seeks to obtain a new type of antitumor active substance from marine microorganisms, which have not been studied in the past as sources of antitumor active substances.
本発明者等は、海洋性微生物を扱う際にしばしば遭遇す
る種々の困難を解決し、広く海洋性微生物を研究した結
果、アルテロモナス(Alteromonas)属に属
する新規微生物が新しいタイプの抗腫瘍活性物質を生産
することを見出し、本発明を完成した。The present inventors solved various difficulties often encountered when dealing with marine microorganisms, and as a result of extensive research on marine microorganisms, a new microorganism belonging to the genus Alteromonas has a new type of antitumor active substance. They discovered that it can be produced and completed the present invention.
従って本発明は、アルテロモナス属の微生物により生産
される新規抗腫瘍活性物質SATS2542、該物質を
生産するアルテロモナス属の新規微生物、及び該微生物
を培養し、この培養物から前記抗腫瘍活性物質を採取す
ることを特徴とする該抗腫瘍活性物質の製造方法を提供
しようとするものである。Therefore, the present invention provides a novel anti-tumor active substance SATS2542 produced by a microorganism of the genus Alteromonas, a new microorganism of the genus Alteromonas that produces the substance, and the method of culturing the microorganism and collecting the anti-tumor active substance from this culture. The present invention aims to provide a method for producing the antitumor active substance, which is characterized by the following.
本発明の抗腫瘍活性物質SATS2542は次の性質を
有する。The antitumor active substance SATS2542 of the present invention has the following properties.
1、分解点:213℃〜245℃の間で褐変し分解する
。1. Decomposition point: browns and decomposes between 213°C and 245°C.
2、比旋光度: 〔α〕乙0=+25° (c =0.
02゜H2O)
3、 紫外吸収スペクトル: Q、02%水溶液のスペ
クトルに220〜360nmで特徴的な吸収を示さない
。2. Specific optical rotation: [α] 0 = +25° (c = 0.
02°H2O) 3. Ultraviolet absorption spectrum: Q. The spectrum of the 02% aqueous solution shows no characteristic absorption in the range of 220 to 360 nm.
このチャートを第1図に示す。This chart is shown in FIG.
4、赤外吸収スペクトル:KBrディスクによる測定に
おいて3300 、1640cm−’付近にペプチドに
よる吸収を示し、840cm−’付近に糖による吸収を
示す。このチャートを第2図に示す。4. Infrared absorption spectrum: In measurement using a KBr disk, absorption due to peptides is shown at around 3300 and 1640 cm-', and absorption due to sugar is shown at around 840 cm-'. This chart is shown in FIG.
5、塩基性、酸性、中性の区別:1.Omg/mfの水
溶液は弱酸性〜中性を示す。5. Distinction between basic, acidic, and neutral: 1. Omg/mf aqueous solution exhibits weak acidity to neutrality.
6、物質の色:わずかに褐色を帯びた白色。6. Color of substance: White with a slight brownish tinge.
7、溶剤への溶解度:水に可溶性であり、アルコール類
、アセトン、エーテル、ヘキサン、クロロホルム、酢酸
エチル等の有機溶剤に難溶又は不溶である。7. Solubility in solvents: Soluble in water, poorly soluble or insoluble in organic solvents such as alcohols, acetone, ether, hexane, chloroform, and ethyl acetate.
8、分子量ニゲル濾過法による測定では100,000
以上を示す。8. Molecular weight: 100,000 when measured by Nigel filtration method
The above is shown.
9、呈色反応
ビューレット反応 十
ニンヒドリン反応 −
フォリン反応 十
アンスロン硫酸反応 士
システィン硫酸反応 十
以上の知見により物質SATS2542は糖および蛋白
により構成されていると推定される。9. Color reaction Buret reaction Juninhydrin reaction - Folin reaction Tenanthrone sulfuric acid reaction Cysteine sulfuric acid reaction Based on more than ten findings, it is estimated that the substance SATS2542 is composed of sugar and protein.
後に具体的に示すごとく、この物質SATS2542は
マウスリンパ性白血病細胞P388を用いるin vi
tr。As specifically shown later, this substance SATS2542 was produced in vitro using mouse lymphocytic leukemia cells P388.
tr.
活性試験において、50%増殖阻止濃度IC,。In the activity test, 50% inhibitory concentration IC.
1、8 X 10−3n/m!を持つ強力な抗腫瘍剤で
ある。1,8 x 10-3n/m! It is a powerful antitumor agent.
本発明において使用する微生物は、アルテロモナス属に
属し、物質SATS2542を生産する事が出来るもの
であればよく、このような微生物は自然界から新たに分
離する事ができる。The microorganisms used in the present invention may belong to the genus Alteromonas and can produce the substance SATS2542, and such microorganisms can be newly isolated from nature.
アルテロモナスに属する微生物の例として、物質SAT
S2542産生能を持つ微生物として本発明者等が新た
に分離し、アルテロモナス(Alteromonas)
属に属する新規微生物と同定した5CRC−2542を
挙げる事が出来る。この新菌株アルテロモナス属に属す
る新規微生物5CRC−2542は工業技術院微生物工
業技術研究所に微工研菌寄第9819号として寄託され
ている。As an example of a microorganism belonging to Alteromonas, the substance SAT
The present inventors newly isolated a microorganism capable of producing S2542, Alteromonas.
We can mention 5CRC-2542, which was identified as a new microorganism belonging to the genus. This new strain of microorganism 5CRC-2542 belonging to the genus Alteromonas has been deposited with the Institute of Microbial Technology, Agency of Industrial Science and Technology as Microbiological Laboratory No. 9819.
この新菌株は次のように分離した。This new bacterial strain was isolated as follows.
次の表に示す組成の培地を調整した。A medium having the composition shown in the table below was prepared.
肉エキス 1.0%
ペプトン 160%
NaCl 0.5%
寒 天 1.5%水道水
pl+7.0
この寒天平板培地に各地の海洋より採取した海洋性サン
プルを滅菌した生理食塩水で適度に希釈したものを接種
し、25℃で1〜2日間培養した。Meat extract 1.0% Peptone 160% NaCl 0.5% Agar 1.5% Tap water
pl+7.0 This agar plate medium was inoculated with marine samples collected from various oceans, diluted appropriately with sterilized physiological saline, and cultured at 25° C. for 1 to 2 days.
この寒天平板培地に出現したコロニーを同じ培地組成の
斜面培地に釣菌した。Colonies that appeared on this agar plate were plated onto a slanted medium with the same medium composition.
このようにして各地の海洋より採取した海洋性サンプル
から多数の菌株を分離した。次に表の培地より寒天を抜
いたものを試験管に5mJずつ分注し、同様に滅菌した
。それぞれの菌株をこの培地で25°C21〜2日間培
養した。このようにして、物質SATS2542を生産
する下記の菌株を相模湾より採取した海洋性サンプルよ
り得た。In this way, a large number of bacterial strains were isolated from marine samples collected from oceans around the world. Next, the agar was removed from the medium shown in the table, and 5 mJ each was dispensed into test tubes, which were sterilized in the same manner. Each strain was cultured in this medium at 25°C for 21 to 2 days. In this way, the following bacterial strain producing the substance SATS2542 was obtained from a marine sample collected from Sagami Bay.
この新規な菌株は、次のような菌学的性質を有する。This new strain has the following mycological properties.
観察項目
a)形態
■ 細胞の形 短かん菌大きさ
1. OX 2.0μm2 多形性の有
無 無
3 運動性の有無 有
鞭毛の着生状態 単極上
4 胞子の有無 無
5 グラム染色 陰性
6 抗酸性 陰性
b)各培地に於ける生育状態
1 肉汁寒天平板培養(25℃、2日間)イ)コロニー
形状(直径)1.5〜2.01鳳O)コロニーの形
円形
ハ)コロニー表面の形状 平滑
二)コロニーの隆起状態 台状
ネ)コロニーの周縁 金縁
へ)コロニーの色調 淡黄色
ト)コロニーの透明度 半透明
チ)コロニーの光沢 光沢
り)可溶性色素の生成 無
2 肉汁寒天斜面培養(25℃、2日間)イ)生育の良
否 良好
■)コロニーの光沢 光沢
3 肉汁液体培地(25℃、2日間)
イ)表面の生育 無
o)濁度 濁る
ハ)沈殿 粉状
二)ガス発生 無
4 肉汁ゼラチン(25℃、2日間)
ゼラチン液化 液化
5 リドマスミルク 還元・凝固・液化
C)生理学的性質
1 硝酸塩の還元 +2 脱窒
−3MR−
4VP −5インドール生
成 −
6硫化水素の生成 −
7デンプンの加水分解 −
8クエン酸利用
イ) Koser
−0) Christensen
+9 硝酸塩の利用 −1
0色素生成
イ) King 八 培地
−n) King B培地
−1)ウレアーゼ −12オキシ
ダーゼ +13 カタラーゼ
+14 生育の範囲
イ)p)I
6 〜100)温度
5℃〜30℃15 酸素に対する態度 好気
性160−Fテスト(グルコース) −17糖類から
酸及びガス生成
1、L−アラビノース −
2、D−ギシロース −
3、D−グルコース +
4、D−マンノース −
5、D−フラクトース ±
6、D−ガラクトース −
7、麦芽糖 −
8、シー!糖 −9、乳糖
−10、トレハロース
−1)、0−ソルビット −12
、D−マンニット −13、イノシフト
−14、グリセリン
−
15、デンプン −(ただしガス
の生成 全項目−)
d) その他の諸性質
SS寒天培地での生育 十
マツコンキー寒天培地での生育 +
6.5%NaC1耐塩性 十DNase
十
オルニチンの分解 −
アルギニンの分解 −
C+C含量 46.3%ゼラチンの
分解 十
NaCj!要求性 十以上のような諸
性質から、本菌株5CRC−2542は下記の大きな特
徴を持つ。Observation items a) Morphology ■ Cell shape Short bacterium size
1. OX 2.0 μm2 Presence or absence of polymorphism No 3 Presence or absence of motility Flagellated epiphytic status Monopolar 4 Presence or absence of spores No 5 Gram staining Negative 6 Acid-fast negative b) Growth status in each medium 1 Broth agar plate culture (25℃, 2 days) A) Colony shape (diameter) 1.5-2.01 O) Colony shape
Circular C) Colony surface shape Smooth 2) Protruding state of the colony Tablet-shaped C) Peripheral edge of the colony To the golden edge) Color tone of the colony Pale yellow G) Transparency of the colony Translucent C) Gloss of the colony Gloss) Production of soluble pigment None 2 Meat juice agar slant culture (25℃, 2 days) a) Quality of growth Good ■) Colony gloss Gloss 3 Meat juice liquid medium (25℃, 2 days) a) Surface growth No o) Turbidity Cloudy c) Precipitation Powder 2) Gas generation None 4 Meat juice gelatin (25℃, 2 days) Gelatin liquefaction Liquefaction 5 Lidomus milk Reduction/coagulation/liquefaction C) Physiological properties 1 Nitrate reduction +2 Denitrification
-3MR- 4VP -5 Indole production - 6 Hydrogen sulfide production - 7 Starch hydrolysis - 8 Citric acid utilization a) Koser
-0) Christensen
+9 Use of nitrates -1
0 pigment production a) King 8 medium
-n) King B medium
-1) Urease -12 Oxidase +13 Catalase
+14 Growth range a) p) I
6-100) Temperature
5°C to 30°C15 Attitude towards oxygen Aerobic 160-F test (glucose) - Acid and gas production from 17 sugars 1, L-arabinose - 2, D-gysylose - 3, D-glucose + 4, D-mannose - 5, D-Fructose ± 6, D-Galactose - 7, Maltose - 8, Sea! Sugar -9, lactose
-10, trehalose
-1), 0-Sorbit -12
, D-Mannitol-13, Inoshift-14, Glycerin
- 15, Starch - (However, gas production - all items -) d) Other properties Growth on SS agar medium Growth on Ten Pine Conkey agar medium + 6.5% NaCl salt tolerance Ten DNase
Decomposition of 10 ornithine - Decomposition of arginine - C+C content 46.3% Decomposition of gelatin 10 NaCj! Requirements From the ten or more properties, this strain 5CRC-2542 has the following major characteristics.
■ ダラム陰性
■ 運動性を持つ
■ 非胞子形成の好気性かん菌
■ O−Fテスト陰性
■ 力゛タラーゼ、オキシダーゼ陽性
■ −本の極鞭毛を持つ
■ ゼラチン、DNA分解能を持つ
■ グルコースからの酸産生(+)、ガス産生(−)■
NaC1または海水要求性
[相] G+C含量 46.3%
■ 硝酸塩還元能を持つ
0 オルニチン分解能(−)
このような諸性質を有する本菌株5CRC−2542株
の分類学的な位置は、バージイズ・マニュアル・オブ・
ディタミナティプ・バタテリオロジー(Bergey’
s Manual of Determinative
Bacteriology)第8版、1974年、及
びバージイズ・マニュアル・オブ・システマティク・バ
クテリオロジー(Bergey’ sManual o
f Systematic Bacteriology
)第1巻、343〜352頁、1984年の分類基準、
さらにマニュアル・オブ・クリニカル・マイクロバイオ
ロジー(Manual of C1)nical Mi
crobiology)第3版−1980年及びジャー
ナル・オブ・ゼネラル・マイクロバイオロジー(Jou
rnal of General Microbiol
ogy)1293057−3074(1983)等の文
献に従って、次のように同定した。■ Durham negative ■ Motile ■ Non-spore-forming aerobic bacterium ■ O-F test negative ■ Positive for dithalase and oxidase ■ - has book polar flagella ■ Gelatin, has DNA-degrading ability ■ Acid from glucose Production (+), gas production (-) ■
NaCl or seawater auxotrophy [phase] G+C content 46.3% ■ Has nitrate reducing ability 0 Ornithine degrading ability (-) The taxonomic position of this strain 5CRC-2542, which has these properties, can be found in the Verge's Manual ·of·
Bergey'
s Manual of Determinative
Bacteriology, 8th edition, 1974, and Bergey's Manual of Systematic Bacteriology.
f Systematic Bacteriology
) Volume 1, pp. 343-352, 1984 classification criteria,
Furthermore, Manual of Clinical Microbiology (Manual of C1) clinical Mi
crobiology) 3rd edition - 1980 and Journal of General Microbiology (Jou
rnal of General Microbiol
ogy) 1293057-3074 (1983), it was identified as follows.
上記■から[相]までの項目については、アルテロモナ
ス・ピユートリファシェンス(A l teromon
as匹扛畦赳圏旦)と一致した。しかしながら、硝酸塩
還元能を持ち、またオルニチン分解能や、クエン酸・麦
芽糖・シヨ糖利用゛能を持たないことから、本菌株はア
ルテロモナス(Alteromonas )属に属する
新規微生物であると同定した。Regarding the items from ■ to [phase] above, Alteromonas pyurefaciens (A l teromon
It matched with (as to take a look at). However, this strain was identified as a new microorganism belonging to the genus Alteromonas because it has the ability to reduce nitrate and does not have the ability to degrade ornithine or utilize citric acid, maltose, or sucrose.
以上、自然界から分離したこの新菌株について詳細に記
載したが、この菌に変異を生じさせて一層生産性の高い
菌株を得ることも出来る。Although this new bacterial strain isolated from nature has been described in detail above, it is also possible to obtain a strain with even higher productivity by causing mutations in this bacteria.
この発明の菌株は、常法に従って保存することが出来、
例えば寒天スラント培地上で、または凍結乾燥法により
保存することが出来る。寒天スラント培地としては、ア
ルテロモナス属細菌の保存に常用されている培地、例え
ば菌の分離に関して前記した培地を使用することが出来
る。また、凍結乾燥保存も常法に従って行なうことが出
来る。The strain of this invention can be stored according to conventional methods,
For example, it can be stored on an agar slant medium or by freeze-drying. As the agar slant medium, a medium commonly used for preserving Alteromonas bacteria, such as the medium described above for bacterial isolation, can be used. Furthermore, freeze-drying preservation can be carried out according to conventional methods.
前記の微生物を培養して本発明の物質SATS2542
を製造しようとする場合、基礎栄養培地として、この発
明の微生物が増殖しうるちのであればいずれを使用して
も良い。The substance of the present invention SATS2542 is obtained by culturing the above-mentioned microorganism.
When producing a microorganism, any basic nutrient medium may be used as long as the microorganism of the present invention can grow therein.
この培地は、窒素源として例えば酵母エキス、ペプトン
、肉エキス等の1種類または複数種類を含有する。また
この培地には必要に応じて炭素源として各種の1!類を
加えることが出来る。この培地には、塩化ナトリウム、
もしくは天然海水や人工海水を加えることが必要である
。This medium contains one or more nitrogen sources, such as yeast extract, peptone, meat extract, and the like. In addition, this medium may contain various types of 1! as a carbon source if necessary. You can add types. This medium contains sodium chloride,
Alternatively, it is necessary to add natural seawater or artificial seawater.
培養は固体培地または液体培地のいずれを用いても良い
が、目的とする物質SATS2542を多量に得る為に
は、液体培地を用い、静置培養もしくは振とう培養、通
気・撹拌培養等により好気条件下で培養を行なうのが好
ましい。培養温度は菌が生育し、物質SATS2542
が生産される温度範囲であればいずれの温度でも良く、
好ましくは5〜30 ”Cであり、より好ましくは15
〜25℃である。pHは6〜9、好ましくは7〜8の範
囲である。培養時間は採取し得る量の物質SATS25
42が生産される時間を選べば良く、好ましくは8〜4
8時間である。Either a solid medium or a liquid medium may be used for culture, but in order to obtain a large amount of the target substance SATS2542, a liquid medium is used and aerobic culture is performed using static culture, shaking culture, aeration/agitation culture, etc. It is preferable to carry out the culturing under these conditions. The culture temperature is such that the bacteria grow and the substance SATS2542
Any temperature is acceptable as long as it is produced within the temperature range.
Preferably 5-30"C, more preferably 15"C
~25°C. The pH ranges from 6 to 9, preferably from 7 to 8. The incubation time is the amount of material that can be collected.SATS25
Just choose the time when 42 is produced, preferably 8 to 4
It is 8 hours.
次に得られた培養物から例えば次のようにして本発明の
物質SATS2542が採取される。Next, the substance SATS2542 of the present invention is collected from the obtained culture, for example, in the following manner.
上記の培養液をまず遠心分離によって菌体を沈めた後の
上澄を0.2 ttmの滅菌フィルターを通して菌体を
除去した。ついで限外濾過により活性物質を濃縮した。The above culture solution was first centrifuged to submerge the bacterial cells, and the supernatant was passed through a 0.2 ttm sterilization filter to remove the bacterial cells. The active substance was then concentrated by ultrafiltration.
これを硫酸アンモニウムによる分画を行ない、50%の
飽和硫酸アンモニウム溶液で沈降する部分を集めた。つ
いでセファクリルS−300を用いてゲル濾過し、0.
2 M NaCj!水溶液で溶出させ、P2S5を用
いる活性試験で活性を示す部分を集めた。半透膜を用い
て脱塩をした後、凍結乾燥してSATS2542を得た
。This was fractionated using ammonium sulfate, and the precipitated portion was collected with a 50% saturated ammonium sulfate solution. Then, gel filtration was performed using Sephacryl S-300 to obtain a 0.
2 M NaCj! It was eluted with an aqueous solution, and a portion showing activity in an activity test using P2S5 was collected. After desalting using a semipermeable membrane, the product was freeze-dried to obtain SATS2542.
以下実施例、及び試験例によりさらにくわしく説明する
が、この方法にのみ限定されるものではない。The method will be explained in more detail below using Examples and Test Examples, but is not limited to this method.
肉エキス1.0%、ペプトン1.0%、NaCj20.
5%を含有し、pH7,0に調整した培地101を12
1℃、15分間加熱殺菌したのち、アルテロモナス属に
属する新規微生物5CRC−2542(?A工研菌寄第
9819号)を接種し、25℃で24時間好気的に培養
した。培養後、遠心分離機で上澄を採取した。Meat extract 1.0%, peptone 1.0%, NaCj 20.
Medium 101 containing 5% and adjusted to pH 7.0 was added to 12
After heat sterilization at 1°C for 15 minutes, a new microorganism belonging to the genus Alteromonas, 5CRC-2542 (?A Koken Bacterial Collection No. 9819), was inoculated and cultured aerobically at 25°C for 24 hours. After culturing, the supernatant was collected using a centrifuge.
こうして得られた培養上澄(101)を滅菌フィルター
(0,2m)をかけた後分画分子量30000の限外濾
過膜(アミコン社)を用いて150 +nlに濃縮した
。この濃縮液に硫安を添加し、50%飽和度で沈降した
両分を遠心分離により分取、これを約3−の水溶液とし
、セファクリルS−300カラム(IX37cm)にの
せ、0.2M NaC1テ溶出し、培養細胞P388
に対して増殖阻害活性のある両分(A)を分取した。溶
出曲線を第3図に示す。Aの活性画分溶出液を透析膜で
脱塩した後、凍結乾燥し、抗腫瘍性物質SMAS254
2を7■得た。The culture supernatant (101) thus obtained was filtered through a sterile filter (0.2 m) and concentrated to 150 + nl using an ultrafiltration membrane with a molecular weight cutoff of 30,000 (Amicon). Ammonium sulfate was added to this concentrated solution, and both fractions that precipitated at 50% saturation were separated by centrifugation. This was made into an aqueous solution of about 3-3%, placed on a Sephacryl S-300 column (IX 37 cm), and 0.2M NaC1 column was added. Elute and culture cells P388
Both fractions (A) having growth-inhibitory activity against . The elution curve is shown in FIG. The active fraction eluate of A was desalted with a dialysis membrane and then lyophilized to form the antitumor substance SMAS254.
I got 7■ of 2.
拭駄貫 披脹裔活比(2)離間
本発明の物質SATS2542の抗腫瘍性活性を次の様
にして確認した。The antitumor activity of SATS2542, the substance of the present invention, was confirmed as follows.
マウスリンパ性白血病細胞(P2S5)を10%牛脂児
血清含有のRPMI−1640培養液に加え、培養細胞
を5X10’個/m1に調整し、実施例1.で得られた
物質SATS2542を所定の濃度になるように添加し
、37℃で2日間培養した。コールタ−カウンターを用
い、浮遊細胞数を計数して、対照群に対する増殖阻害率
から、50%細胞増殖阻害濃度(IC5゜)を求めた。Mouse lymphocytic leukemia cells (P2S5) were added to RPMI-1640 culture medium containing 10% tallow serum, and the cultured cells were adjusted to 5 x 10' cells/ml. The substance SATS2542 obtained in 1 was added to a predetermined concentration and cultured at 37°C for 2 days. The number of floating cells was counted using a Coulter counter, and the 50% cell growth inhibition concentration (IC5°) was determined from the growth inhibition rate relative to the control group.
結果を次の表に示す。The results are shown in the table below.
SATS2542
1.8 X 1 0 弓ADM (既知物質)
1.3X10づ5−FU (既知物質>
4.9X10−2SATS2542
1.8 x 10 Bow ADM (known substance)
1.3X105-FU (known substance>
4.9X10-2
第1図は本発明の実施例1.で得られた物質SATS2
542の紫外線吸収スペクトル図である。
第2図は本発明の実施例1.で得られた物質SATS2
542の赤外線吸収スペクトル図である。
第3図は、セファクリルS−300カラムを用いるクロ
マトグラフィーにおける本発明の実施例1.で得られた
物質SATS2542の溶出の様子を示すグラフである
。FIG. 1 shows Example 1 of the present invention. The substance obtained in SATS2
542 is an ultraviolet absorption spectrum diagram. FIG. 2 shows Example 1 of the present invention. The substance obtained in SATS2
542 is an infrared absorption spectrum diagram. FIG. 3 shows Example 1 of the present invention in chromatography using a Sephacryl S-300 column. 2 is a graph showing the state of elution of the substance SATS2542 obtained in FIG.
Claims (1)
する微生物により生産される下記の理化学的性質を有す
る抗腫瘍活性物質SATS2542: (1)分解点:213℃〜245℃の間で褐変し分解す
る; (2)比旋光度:〔α〕^2^0_D=+25゜(c=
0.02、H_2O); (3)紫外線吸収スペクトル:0.02%水溶液のスペ
クトルに220nm〜360nmの範囲で特徴的な吸収
を示さない; (4)赤外線吸収スペクトル:KBrディスクによる測
定において3300cm^−^1及び1640cm^−
^1付近にペプチドによる吸収を示し、840cm^−
^1付近に糖による吸収を示す; (5)塩基性、酸性、中性の別:1.0mg/mlの水
溶液は弱酸性〜中性を示す; (6)溶剤への溶解性:水に可溶であり、アルコール類
、アセトン、エチルエーテル、ヘキサン、クロロホルム
、酢酸エチル等の有機溶剤に難溶又は不溶である; (7)分子量:ゲル濾過法により測定した場合、100
,000以上である; (8)次の呈色反応を示す: ビューレット反応+ ニンヒドリン反応− フォリン反応+ アンスロン硫酸反応+ システイン硫酸反応+。 2、請求項1に記載の抗腫瘍活性物質SATS2542
を生産するアルテロモナス(Alteromonas)
属微生物。 3、前記微生物がアルテロモナスsp.SCRC−25
42(微工研菌寄第9819号)である請求項2に記載
の微生物。 4、請求項2に記載の微生物を培養し、その培養液から
請求項1に記載の抗腫瘍活性物質SATS2542を採
取することを特徴とする抗腫瘍活性物質SATS254
2の製造方法。[Claims] 1. SATS2542, an antitumor active substance produced by microorganisms belonging to the genus Alteromonas and having the following physical and chemical properties: (1) Decomposition point: browns and decomposes between 213°C and 245°C. (2) Specific optical rotation: [α]^2^0_D=+25°(c=
(0.02, H_2O); (3) Ultraviolet absorption spectrum: The spectrum of a 0.02% aqueous solution shows no characteristic absorption in the range of 220 nm to 360 nm; (4) Infrared absorption spectrum: 3300 cm^ when measured with a KBr disk. -^1 and 1640cm^-
Absorption due to peptide is shown near ^1, 840 cm^-
Absorption by sugars occurs near ^1; (5) Basic, acidic, and neutral: 1.0 mg/ml aqueous solution is weakly acidic to neutral; (6) Solubility in solvents: in water It is soluble and poorly soluble or insoluble in organic solvents such as alcohols, acetone, ethyl ether, hexane, chloroform, and ethyl acetate; (7) Molecular weight: 100 when measured by gel filtration method.
. 2. Antitumor active substance SATS2542 according to claim 1
Alteromonas produces
Genus Microorganisms. 3. The microorganism is Alteromonas sp. SCRC-25
3. The microorganism according to claim 2, which is 42 (Feikoken Bibori No. 9819). 4. Antitumor active substance SATS254, characterized in that the microorganism according to claim 2 is cultured, and the antitumor active substance SATS2542 according to claim 1 is collected from the culture solution.
2. Manufacturing method.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63015754A JPH01191694A (en) | 1988-01-28 | 1988-01-28 | Substance having antitumor activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63015754A JPH01191694A (en) | 1988-01-28 | 1988-01-28 | Substance having antitumor activity |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH01191694A true JPH01191694A (en) | 1989-08-01 |
Family
ID=11897563
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63015754A Pending JPH01191694A (en) | 1988-01-28 | 1988-01-28 | Substance having antitumor activity |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH01191694A (en) |
-
1988
- 1988-01-28 JP JP63015754A patent/JPH01191694A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0459367B1 (en) | Method for preparing an antitumor dextran | |
US4209507A (en) | Novel anti-tumor substance and preparation thereof | |
JPH01191694A (en) | Substance having antitumor activity | |
JPS595278B2 (en) | New antibiotic PO-357 substance and its manufacturing method and uses | |
JPS6327484A (en) | Bisucaberin and production thereof | |
JPH0322994A (en) | Antitumor-active substance sats 6504 | |
EP0084334B1 (en) | Polysaccharide substance, process for the production of same, pharmaceutical compositions containing the same and their use as medicaments | |
EP0053800B1 (en) | Heteroglycan, process for the production of same, and immunological activator containing same | |
JPS58121798A (en) | Polysaccharide mp-67 and its production | |
JP2630391B2 (en) | A new strain belonging to Lactobacillus and method for its isolation and propagation | |
JPS59220197A (en) | Novel nitrogen-containing polysaccharide and its preparation | |
HU181104B (en) | Process for producing 41 200 rp material of immunity-developing activity | |
JPH0223864A (en) | Lactobacillus sp.kpb-167 and production of mucopolysaccharides by said lactobacillus | |
NO159452B (en) | PROCEDURE FOR THE PREPARATION OF A CARCINOSTATIC SUBSTANCE. | |
CN116286528A (en) | Lactobacillus reuteri CKCC11157 strain and application thereof in preparation of hyperuricemia and gout resisting products | |
JPH01238579A (en) | Substance y-05460m-a and production thereof | |
JPS62210996A (en) | Production of antibiotic substance emimycin | |
JPS62285A (en) | Killer factor kh-ii and production thereof | |
JPH03291232A (en) | Antitumor agent and immunoactivator | |
JPS5946502B2 (en) | New antibiotic polymyxin T↓1 | |
JPS61141895A (en) | Novel nucliec acid polymer containing nucleic acid as a component and its preparation | |
JPS5886087A (en) | Novel antibiotic substance sf-2132 and its preparation | |
JPS6172789A (en) | 7-formylamino-cephem compound and its production | |
JPH0460632B2 (en) | ||
JPS61274693A (en) | Novel antibiotic ss21020c and production thereof |